“NSCLC Market” report has been added to DelveInsight

 

The NSCLC market report provides an edge while developing business strategies, by understanding trends shaping and driving the 7MM NSCLC market.

 

NSCLC Disease Overview

NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers. However, NSCLC metastasizes to other organs slower in comparison to SCLC, and microscopically, SCLC is composed of much smaller cells. NSCLC is mainly subcategorized into adenocarcinomas, squamous cell carcinomas, large cell carcinomas and several other types that occur less frequently include adenosquamous carcinomas, and sarcomatoid carcinomas.

 

Download free sample copy here- https://www.delveinsight.com/sample-request/non-small-cell-lung-carcinoma-nsclc-market

 

NSCLC Market: Geography Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

 

NSCLC Key Players

• Genentech
• AstraZeneca
• Bristol-Myers Squibb
• Hoffmann-La Roche
• Merck
• Novartis

 

NSCLC Drugs

• Rozlytrek (Entrectinib)
• Imfinzi (Durvalumab)
• Opdivo (Nivolumab)
• Tecentriq (Atezolizumab)

 

NSCLC Market Report

NSCLC can be located in the mid-chest, but it is often also found in other parts of the lung too. Even though NSCLCs are associated with cigarette smoking, adenocarcinomas may also be found in patients who have never smoked. Also, it is relatively insensitive to chemotherapy and radiation therapy in comparison with SCLC.

 

NSCLC Treatment

Currently the mainstay of treatment is immune checkpoint inhibitors, combination of targeted and immunotherapy with chemotherapy. Although in future, scenario is going to be changed as most of the companies are targeting specific mutations to treat the NSCLC patients.

 

NSCLC Market Growth

Growth of NSCLC Market is expected to be driven by increasing incident case of NSCLC, continue uptake of approved therapies mainly immune checkpoint inhibitors, expected entry of potential premium price emerging therapies and increasing awareness of mutations like BRAF, c-Met and others; currently there is a lack of potential treatment options for these mutations but now companies are working thoroughly towards the development of mutation specific therapies.

 

NSCLC Market Insights

There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery

 

NSCLC Market Report Highlights

• In the coming years, NSCLC market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence NSCLC R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition      
• Major players are involved in developing therapies for NSCLC. Launch of emerging therapies will significantly impact the NSCLC market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for NSCLC
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

 

Following is the TOC of NSCLC market report

1. Key Insights

2. Executive Summary of NSCLC

3. Competitive Intelligence Analysis for NSCLC

4. NSCLC : Market Overview at a Glance

5. NSCLC : Disease Background and Overview

6. Patient Journey

7. NSCLC Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of NSCLC Treatment

11. Marketed Products

12. Emerging Therapies

13. NSCLC : Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of NSCLC

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Why should you buy this NSCLC market report?

• The report will help in developing business strategies by understanding trends shaping and driving the NSCLC market
• To understand the future market competition in the NSCLC market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for NSCLC in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for NSCLC market
• To understand the future market competition in the NSCLC market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Vinita Rakheja
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: www.delveinsight.com/